Opportunity
New York State Contract Reporter #2134268
Sole Source Procurement of Genetic Screening Processors for Newborn Screening Program
Posted
April 22, 2026
Respond By
May 13, 2026
Identifier
2134268
NAICS
334516
This procurement opportunity involves the acquisition of genetic screening processors for the New York State Department of Health's Newborn Screening Program. - Government Buyer: - New York State Department of Health (NYS DOH), Wadsworth Center, HPA1 office - OEM and Vendor: - Revvity Health Sciences, Inc. (sole manufacturer and service provider) - Products Requested: - Two (2) Genetic Screening Processors - No specific part numbers provided - Intended for use in the Newborn Screening Program - Notable Requirements: - Sole source procurement justified as Revvity Health Sciences, Inc. is the only manufacturer and service provider for these processors - No additional unique technical or service requirements specified - Place of Performance and Delivery: - Empire State Plaza, Albany, New York 12237 (primary government facility) - Albany, NY (city location) - Period of Performance: - Approximately 17 months, from after November 10, 2025 through March 31, 2027
Description
The New York State Department of Health intends to contract with Revvity Health Sciences, Inc. for the purchase of two genetic screening processors for the Newborn Screening Program. The contract term is from November 10, 2025 to March 31, 2027. A competitive procurement was not feasible because Revvity Health Sciences, Inc. is the sole manufacturer and service provider of the genetic screening processors. The procurement is a sole source acquisition exempt from advertising.